Anti-HIV-1 Microbicides - Chemical Condoms Designed to Limit the Scourge of the HIV-1 Pandemic

Title: Anti-HIV-1 Microbicides - Chemical Condoms Designed to Limit the Scourge of the HIV-1 Pandemic

Volume: 11 Issue: 29

Author(s): S. J. Scholand, J. A. DeSimone and R. J. Pomerantz

Affiliation:

Keywords: anti-hiv agents, anti-infective agents, clinical trials, drug evaluation, preclinical, human immunodeficiency virus type I, nonoxynol-9, sexually transmitted diseases, viral, spermatocidal agents

Abstract: The HIV pandemic continues to spread throughout the world, particularly affecting populations in developing countries. Women now comprise half of those infected. Efforts to limit this scourge need to be maximally implemented. A multi-faceted approach, including the research and advance of microbicides - or chemical condoms - offers promise. Microbicides are self-administered, prophylactic products designed to protect against sexually transmitted pathogens, including HIV-1. Important features include safety, efficacy and user acceptability. This review summarizes some of the important products in the development pipeline.

Cite this article as:

Scholand J. S., DeSimone A. J. and Pomerantz J. R., Anti-HIV-1 Microbicides - Chemical Condoms Designed to Limit the Scourge of the HIV-1 Pandemic, Current Pharmaceutical Design 2005; 11 (29) . https://dx.doi.org/10.2174/138161205774580688